ArticleCell reports2024

An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo.

Nian E Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.